Repligen (NASDAQ:RGEN) Price Target Raised to $205.00 at Royal Bank of Canada
Repligen (NASDAQ:RGEN – Get Free Report) had its price target hoisted by Royal Bank of Canada from $203.00 to $205.00 in a ...
Repligen (NASDAQ:RGEN) Given New $200.00 Price Target at JPMorgan Chase & Co.
Repligen (NASDAQ:RGEN – Get Free Report) had its target price boosted by equities research analysts at JPMorgan Chase & Co.
AlphaGalileo5 小时
New Research Identifies FAM20C as a Critical Protein Kinase in Cancer Progression and ...
A new review published in Genes & Diseases explores the multifaceted role of FAM20C, a Golgi protein kinase, in disease ...
The New York Times20 小时
New York Times - Top Stories
Elon Musk Steps Up Efforts to Cull Federal Work Force Mr. Musk said federal workers must summarize their accomplishments for the week or be forced to leave, borrowing a tactic he used at his ...